JPWO2022162625A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022162625A5 JPWO2022162625A5 JP2023546007A JP2023546007A JPWO2022162625A5 JP WO2022162625 A5 JPWO2022162625 A5 JP WO2022162625A5 JP 2023546007 A JP2023546007 A JP 2023546007A JP 2023546007 A JP2023546007 A JP 2023546007A JP WO2022162625 A5 JPWO2022162625 A5 JP WO2022162625A5
- Authority
- JP
- Japan
- Prior art keywords
- baseline
- composition
- patient
- meters
- amyloidosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163143728P | 2021-01-29 | 2021-01-29 | |
| US63/143,728 | 2021-01-29 | ||
| PCT/IB2022/050785 WO2022162625A1 (en) | 2021-01-29 | 2022-01-29 | Methods of treating al amyloidosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024505923A JP2024505923A (ja) | 2024-02-08 |
| JPWO2022162625A5 true JPWO2022162625A5 (https=) | 2025-02-06 |
| JP2024505923A5 JP2024505923A5 (https=) | 2025-02-06 |
Family
ID=80222587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023546007A Pending JP2024505923A (ja) | 2021-01-29 | 2022-01-29 | Ａｌアミロイドーシスを処置する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20250084153A1 (https=) |
| EP (1) | EP4284829A1 (https=) |
| JP (1) | JP2024505923A (https=) |
| KR (1) | KR20230136643A (https=) |
| CN (1) | CN117098775A (https=) |
| AU (1) | AU2022213010A1 (https=) |
| CA (1) | CA3206326A1 (https=) |
| CL (1) | CL2023002236A1 (https=) |
| IL (1) | IL304755A (https=) |
| JO (1) | JOP20230172A1 (https=) |
| MX (1) | MX2023008835A (https=) |
| TW (1) | TW202332465A (https=) |
| WO (1) | WO2022162625A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12021552135A1 (en) | 2019-03-05 | 2022-08-31 | Prothena Biosciences Ltd | Methods of treating al amyloidosis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018005967A1 (en) * | 2016-06-30 | 2018-01-04 | Prothena Therapeutics Limited | Compositions for treating amyloidosis |
| US11382974B2 (en) * | 2017-08-01 | 2022-07-12 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for treatment of amyloid deposition diseases |
| PH12021552135A1 (en) * | 2019-03-05 | 2022-08-31 | Prothena Biosciences Ltd | Methods of treating al amyloidosis |
-
2022
- 2022-01-28 TW TW111104161A patent/TW202332465A/zh unknown
- 2022-01-29 US US18/273,854 patent/US20250084153A1/en active Pending
- 2022-01-29 CN CN202280024675.2A patent/CN117098775A/zh active Pending
- 2022-01-29 KR KR1020237029277A patent/KR20230136643A/ko active Pending
- 2022-01-29 WO PCT/IB2022/050785 patent/WO2022162625A1/en not_active Ceased
- 2022-01-29 JP JP2023546007A patent/JP2024505923A/ja active Pending
- 2022-01-29 CA CA3206326A patent/CA3206326A1/en active Pending
- 2022-01-29 AU AU2022213010A patent/AU2022213010A1/en not_active Abandoned
- 2022-01-29 MX MX2023008835A patent/MX2023008835A/es unknown
- 2022-01-29 EP EP22703077.2A patent/EP4284829A1/en active Pending
-
2023
- 2023-07-25 IL IL304755A patent/IL304755A/en unknown
- 2023-07-27 JO JOJO/P/2023/0172A patent/JOP20230172A1/ar unknown
- 2023-07-28 CL CL2023002236A patent/CL2023002236A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7836754B2 (ja) | Ｉｌ－４ｒアンタゴニストを投与することによりアレルギーを治療しアレルゲン特異的免疫療法を増強するための方法 | |
| RU2721910C2 (ru) | Фармацевтическая композиция, предназначенная для применения для предупреждения и/или лечения заболевания, которое развивается или прогрессирует вследствие снижения или утраты активности фактора свертывания крови viii и/или активированного фактора свертывания крови viii | |
| JP6460993B2 (ja) | 血管疾患及びその合併症の処置 | |
| JP2021113190A5 (https=) | ||
| US20250075007A1 (en) | Treatment of Al Amyloidosis with the Combination of Monoclonal Antibodies Agains Immunoglobulin Light Chains and the CD38 Cell Membrane Molecule on Antibody-Producing And Other Immune Cells | |
| JP2019519584A5 (https=) | ||
| JP2024537163A (ja) | 肥満細胞関連障害の治療 | |
| US20240043543A1 (en) | Anti-galectin-9 antibodies and therapeutic uses thereof | |
| KR20250016223A (ko) | 항인슐린 수용체 항체를 위한 제형 및 이의 용도 | |
| IL323497A (en) | Methods for treating eosinophilic gastroenteritis by administering an IL-4R antagonist | |
| ZA200608884B (en) | Methods of treating autoimmune and inflammatory diseases | |
| JPWO2022162625A5 (https=) | ||
| JPWO2020178638A5 (https=) | ||
| TW202432600A (zh) | 用於治療肥胖症之方法 | |
| CN119486744A (zh) | 艾萨妥昔单抗联合其他药物用于治疗多发性骨髓瘤的用途 | |
| JP2024517796A (ja) | 抗ｂａｆｆｒ抗体を使用するループス腎炎の治療 | |
| JPWO2019186369A5 (https=) | ||
| US20230338496A1 (en) | Vaccination against diabetes, obesity and complications thereof | |
| US11623003B2 (en) | Vaccination against diabetes, obesity and complications thereof | |
| KR20260057482A (ko) | 항인슐린 수용체 항체에 대한 고농도 제형 및 그의 용도 | |
| AU2017321682B2 (en) | Methods for preventing or treating allergy by administering an IL-4R antagonist | |
| AU2024326775A1 (en) | High concentration formulations for anti-insulin receptor antibody and uses thereof | |
| JPWO2023215674A5 (https=) | ||
| JPWO2022060955A5 (https=) | ||
| JPWO2020167376A5 (https=) |